 SALT LAKE CITY, Aug. 09, 2021 GLOBE NEWSWIRE -- Health Catalyst, Inc. Health Catalyst Nasdaq: HCAT, a leading provider of data and analytics technology and services to healthcare organizations, today announced the commencement of an underwritten public offering of 225.0 million of shares of its common stock. All of the shares in the offering are being sold by Health Catalyst. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, Health Catalyst intends to grant the underwriters a 30-day option to purchase up to 33.75 million of shares of its common stock in the public offering at the public offering price. 